Company News
GSK Pharma Seeks Shareholder Approval for ₹630 Crore RPT
GSK Pharmaceuticals seeks shareholder approval via postal ballot for related party transactions worth up to ₹630 crore with GSK Biological S.A. for FY 2026-27.
E-voting period runs from November 18 to